Clinical Trial Update: Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update evaluating a novel speech intervention for minimally verbal children with autism spectrum disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Autism | Phase 2, Phase 3 | Status: COMPLETED